Preliminary Data from Long-Term Safety Study Support Chronic Use of ARQ-151 (Topical Roflumilast Cream) as a Potential Treatment for Plaque Psoriasis


You May Also Like

Horizon Pharma plc Named One of the Best Workplaces in Chicago by Fortune

DUBLIN, Ireland, May 25, 2017 (GLOBE NEWSWIRE) -- Horizon Pharma plc (NASDAQ:HZNP), a biopharmaceutical ...

Leap Therapeutics to Present at the 2017 Ladenburg Thalmann Healthcare Conference

CAMBRIDGE, Mass., Sept. 19, 2017 (GLOBE NEWSWIRE) -- Leap Therapeutics, Inc. (NASDAQ:LPTX), a biotechnology ...